NephU

Factors Influencing Drug Dialyzability
2022-10-27 15:00 - 16:00 (America/New_York)
About This Event

Drink Up! How Much Water Is Enough In The Management Of Autosomal Dominant Polycystic Kidney Disease (ADPKD)?
Background

Deciding when to administer a medication around chronic dialysis can be a complex process in the clinical setting. Dr George Bailie and Dr Nancy Mason will present information about the medication-related and dialysis-related factors that influence medication removal by hemodialysis and peritoneal dialysis. They will review medication information resources on this topic, and also present an approach to administration of medications when dialyzability data are limited.

Why Attend This Webinar?

In this webinar, we will review medication information resources and present an approach to administration of medications when dialyzability data are limited in the hemodialysis and peritoneal dialysis populations.

What You Will Learn

Drug-related and dialysis-related factors that influence drug dialyzability
How drug removal by high-flux hemodialysis can be different from that by low-flux hemodialysis
The effects of ratios of systemic volume of distribution to dialysate volume in various peritoneal dialysis regimens on drug clearance
How to use drug information resources to find dialysis dosing recommendations or pharmacokinetic drug data
How to use a step-wise approach to determine the appropriate drug dosing time around dialysis

Featuring

*Drs Bailie and Mason are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Patel is an employee of OPDC.

Registration

Related Resources

Diagnostic Imaging & TKV: A Discussion On Breaking Barriers
2022-11-09 12:00 - 13:00
About This Event

Drink Up! How Much Water Is Enough In The Management Of Autosomal Dominant Polycystic Kidney Disease (ADPKD)?
Background

In patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) kidney size is a strong predictor of disease progression before eGFR begins to decline1. Identifying a total kidney volume (TKV) greater than expected for your patient’s age can provide an early and reliable marker for rapid disease progression which is an important step in management to delay further kidney damage1,2.

Did You Know?

A one-time kidney size measurement can assess the rate of progression of ADPKD and predict the future decline of kidney function3.

Why Attend This Webinar?

For the first time on NephU we are bringing together a Nephrologist and Radiologist to discuss breaking down barriers encountered with TKV orders.

What You Will Learn

Review the strengths and limitations of different imaging modalities Nephrologists can order to obtain a TKV.
Review different methods Radiologists have available to calculate TKV.
Discuss methods to break down communication barriers between the Nephrologist and Radiologist.

References

Grantham J, et al. (2011). Nat Rev Nephrol. 7(10):556-566.
Chapman A, et al. (2012). Clin J Am Soc Nephrol. 7(3):479-486.
Yu A, et al. (2019). Kidney Int. 95(5):1253-1261.

Featuring

*Drs Makkar and Shirazian are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Mohindra is an employee of OPDC.

If you would like to register for the 8:00 pm to 9:00 pm EST broadcast, please click below:

Register For The 8:00 pm Broadcast

Registration

Related Resources

Diagnostic Imaging & TKV: A Discussion On Breaking Barriers
2022-11-09 20:00 - 21:00
About This Event

Drink Up! How Much Water Is Enough In The Management Of Autosomal Dominant Polycystic Kidney Disease (ADPKD)?
Background

In patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) kidney size is a strong predictor of disease progression before eGFR begins to decline1. Identifying a total kidney volume (TKV) greater than expected for your patient’s age can provide an early and reliable marker for rapid disease progression which is an important step in management to delay further kidney damage1,2.

Did You Know?

A one-time kidney size measurement can assess the rate of progression of ADPKD and predict the future decline of kidney function3.

Why Attend This Webinar?

For the first time on NephU we are bringing together a Nephrologist and Radiologist to discuss breaking down barriers encountered with TKV orders.

What You Will Learn

Review the strengths and limitations of different imaging modalities Nephrologists can order to obtain a TKV.
Review different methods Radiologists have available to calculate TKV.
Discuss methods to break down communication barriers between the Nephrologist and Radiologist.

References

Grantham J, et al. (2011). Nat Rev Nephrol. 7(10):556-566.
Chapman A, et al. (2012). Clin J Am Soc Nephrol. 7(3):479-486.
Yu A, et al. (2019). Kidney Int. 95(5):1253-1261.

Featuring

*Drs Makkar and Shirazian are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Mohindra is an employee of OPDC.

Registration

Related Resources

Hyperuricemia In CKD & Specific Considerations In ADPKD
2022-11-17 12:00 - 13:00
About This Event

Drink Up! How Much Water Is Enough In The Management Of Autosomal Dominant Polycystic Kidney Disease (ADPKD)?
Background

Hyperuricemia is frequently associated with a number of other conditions such as hypertension, type 2 diabetes, obesity, heart failure, overweight, and cardiovascular disease. In CKD, the CV mortality is increased with inflammatory gout and inflammatory processes involving uric acid contributing to CKD.

Did You Know?

Did you know that over 50%1 of dialysis patients present with hyperuricemia?

Why Attend This Webinar?

To expand your understanding of hyperuricemia and its impact on CKD and ADPKD patients. As well as discuss some of the controversies around treatment modalities.

What You Will Learn

This webinar will cover biochemistry and physiology of uric acid and its pathway
Will also discuss the pathophysiology of uric acid in gout, CKD, and ADPKD
Discuss therapeutic options and the current controversies around them

References:

Piani F. et al. Hyperuricemia and chronic kidney disease: to treat or not to treat, https://doi.org/10.1590/2175-8239-JBN-2020-U002 Accessed October 2022.

Featuring

*Dr Hanna is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Hagdu is an employee of OPDC.

If you would like to register for the 3:00 pm to 4:00 pm EST broadcast, please click below:

Register For The 3:00 pm Broadcast

Registration

Related Resources

Hyperuricemia In CKD & Specific Considerations In ADPKD
2022-11-17 15:00 - 16:00
About This Event

Drink Up! How Much Water Is Enough In The Management Of Autosomal Dominant Polycystic Kidney Disease (ADPKD)?
Background

Hyperuricemia is frequently associated with a number of other conditions such as hypertension, type 2 diabetes, obesity, heart failure, overweight, and cardiovascular disease. In CKD, the CV mortality is increased with inflammatory gout and inflammatory processes involving uric acid contributing to CKD.

Did You Know?

Did you know that over 50%1 of dialysis patients present with hyperuricemia?

Why Attend This Webinar?

To expand your understanding of hyperuricemia and its impact on CKD and ADPKD patients. As well as discuss some of the controversies around treatment modalities.

What You Will Learn

This webinar will cover biochemistry and physiology of uric acid and its pathway
Will also discuss the pathophysiology of uric acid in gout, CKD, and ADPKD
Discuss therapeutic options and the current controversies around them

References:

Piani F. et al. Hyperuricemia and chronic kidney disease: to treat or not to treat, https://doi.org/10.1590/2175-8239-JBN-2020-U002 Accessed October 2022.

Featuring

*Dr Hanna is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Hagdu is an employee of OPDC.

Registration

Related Resources

Major Depressive Disorder (MDD) In Chronic Kidney Disease (CKD)
2022-12-14 12:00 - 13:00
Thank you for attending, we hope you enjoyed this webinar.
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Drink Up! How Much Water Is Enough In The Management Of Autosomal Dominant Polycystic Kidney Disease (ADPKD)?
Major depressive disorder affects more than 260 million people worldwide.1 The reported prevalence of depression in patients with chronic kidney disease ranges from 20-65%.2 This presentation provides an overview of both MDD and CKD and discusses their overlap of symptomology.

1. World Health Organization. Fact Sheet on Depression. (2012) https://www.who.int/health-topics/depression#tab=tab_1

2. Teles F et al. Clinics (Sao Paulo). 2014 ;69(3):198-202.

Featuring

*Drs Bojrab and Kang are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC).

If you would like to register for the 6:00 pm to 7:00 pm EST broadcast, please click below:

Register For The 6:00 pm Broadcast

Registration

Related Resources

Major Depressive Disorder (MDD) In Chronic Kidney Disease (CKD)
2022-12-14 18:00 - 19:00
Thank you for attending, we hope you enjoyed this webinar.
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Drink Up! How Much Water Is Enough In The Management Of Autosomal Dominant Polycystic Kidney Disease (ADPKD)?
Major depressive disorder affects more than 260 million people worldwide.1 The reported prevalence of depression in patients with chronic kidney disease ranges from 20-65%.2 This presentation provides an overview of both MDD and CKD and discusses their overlap of symptomology.

1. World Health Organization. Fact Sheet on Depression. (2012) https://www.who.int/health-topics/depression#tab=tab_1

2. Teles F et al. Clinics (Sao Paulo). 2014 ;69(3):198-202.

Featuring

*Drs Bojrab and Kang are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC).

Registration

Related Resources

COVID-19 & The Kidneys
2023-01-11 12:00 - 13:00
Thank you for attending, we hope you enjoyed this webinar.
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Drink Up! How Much Water Is Enough In The Management Of Autosomal Dominant Polycystic Kidney Disease (ADPKD)?
Acute kidney injury has been associated with an increased mortality rate among hospitalized patients with COVID-191 and there is evidence to support an increased risk of mortality and hospitalization in patients with chronic kidney disease2. In this webinar, Dr. Yongen Chang discusses the currently known pathophysiology of COVID-19 and important considerations in the care of patients with kidney disease.

References:

Sabaghian et al. COVID-19 and Acute Kidney Injury: A Systematic Review. Front Med. 2022: 1-9
Jdiaa et al. COVID–19 and chronic kidney disease: an updated overview of reviews. Journal of Nephrology. 2022. 35:69–85

Featuring

*Dr Chang is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Patel is an employee of OPDC.

Registration

Related Resources

Cooking Demo With Chef Duane: Three Tasty CKD & PKD Friendly Recipes
2023-01-31 12:00 - 13:00
Thank you for attending, we hope you enjoyed this webinar.
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Drink Up! How Much Water Is Enough In The Management Of Autosomal Dominant Polycystic Kidney Disease (ADPKD)?
Background

The NephChef, featuring Chef Duane Sunwold, shows viewers how to create three delicious kidney friendly recipes. Chef Duane’s own journey with chronic kidney disease (CKD) provided motivation for him to explore palatable and healthy recipes. These three recipes are appropriate for patients in all CKD stages as well as polycystic kidney disease (PKD).

Did You Know?

Adopting a kidney healthy diet can help delay CKD and PKD progression and improve outcomes.

Why Attend This Webinar?

Empowering kidney disease patients to make informed decisions on healthy kidney food choices is key for improved outcomes. We hope that after tuning in you and your patients will find it easier to adopt and sustain a kidney friendly diet.

What You Will Learn

Recipes and cooking demonstration for:

Fresh Plum Compote
Curried Chicken, Rice, and Pineapple Salad
Rice Milk Sorbet

Featuring

*Duane Sunwold is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC).

Registration

Related Resources

Hot Topics in Nephrology – Ketogenic Diets for Polycystic Kidney Disease (PKD): Research Insights & Clinical Translation

Audio/Podcast April 10, 2025

In this episode, Dr. Thomas Weimbs discusses ketogenic diets for polycystic kidney disease (PKD), explaining the science behind ketosis and its potential impact.

Tofu Vegetable Stir-Fry

Recipe March 17, 2025

Recipe provided by Chef Anthony Valentine.

Cooking Demo: Dietary Considerations for Patients with IgA Nephropathy

On-Demand Webinar March 13, 2025

Registered Dietitian Lauren Levy and Kidney-Friendly Chef Anthony Valentine come together to bring their expertise in nutrition and IgAN, including discussing the basics of nutritional concepts – such as sodium…

Panel Discussion – Racial Disparities In Access To Renal Transplantation
2023-02-14 12:00 - 13:00
Thank you for attending, we hope you enjoyed this webinar.
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Drink Up! How Much Water Is Enough In The Management Of Autosomal Dominant Polycystic Kidney Disease (ADPKD)?
Significant racial disparities exist between Black and White Americans in need of kidney transplantation. This healthcare disparity is multifactorial including limited kidney donors for Black Americans, inconsistent care coordination, social determinants of health, reduced access to care, and mistrust of clinicians and the healthcare system.1 Join us for an informative panel discussion as we discuss these challenges and possible solutions to bridge these disparities.

Reference

Harding K, Mersha TB, Pham PT, Waterman AD, Webb FJ, Vassalotti JA, Nicolas SB. Health Disparities in Kidney Transplantation For African Americans. Am J Nephrol. 2017;46:165-175. Doi:10.1159/000479840

Featuring

*Dr Lisa McElroy, Richard Knight and Amy Kozsuch are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC).

Registration

Related Resources

A Panel Discussion: Promoting Awareness Of Rare Kidney Diseases With A Focus On Autosomal Dominant Polycystic Kidney Disease (ADPKD) & IgA Nephropathy (IgAN)
2023-02-28 12:00 - 13:00
Thank you for attending, we hope you enjoyed this webinar.
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Drink Up! How Much Water Is Enough In The Management Of Autosomal Dominant Polycystic Kidney Disease (ADPKD)?
(followed by a live Q&A with our speakers)
Background

An estimated 300 million people around the world live with a rare disease1. About 25-30 million Americans are affected by rare diseases1. There are around 150 different rare kidney diseases; two of the most common are Autosomal Dominant Polycystic Kidney Disease and IgA Nephropathy1. Both rare kidney diseases progress through a person’s lifetime, ultimately leading to kidney damage2,3. If left unmanaged, the damage occurring to the kidney may be substantial enough to result in kidney failure2,3.

Did You Know?

Since its creation in 2008, Rare Disease Day is observed every year on the last day of February (the 29th on leap years – the rarest day of the year)
Glomerular disease (e.g. IgAN) and ADPKD are the 3rd and 4th leading causes of end stage kidney disease, respectively, behind diabetes and hypertension2

Why Attend This Webinar?

Join us for our panel discussion, where experts discuss their passion for ADPKD and IgAN and how the entire kidney community can rally around Rare Disease Day to raise awareness about these rare kidney diseases.

What You Will Learn

Prevalence of rare diseases
Epidemiology of ADPKD and IgAN
Impact on patients and caregivers

References

NephU_Rare Disease Day_2021 Infographic – MRC2.CORP_.X.05794
NephU_Overview of ADPKD Deck – MRC2.CDR.D.00077
NephU_Overview of IgAN_2022 Infographic – US.CORP.X.22.00054

Featuring

Moderators

*Drs Joshua Lipschutz and Shayan Shirazian are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Drs Josh Gariboldi and Hannah Lambert are employees of OPDC.

Registration

Related Resources

Kidney Healthy Cooking Series Featuring Celebrity Chef JJ
2023-03-21 12:00 - 13:00
Thank you for attending, we hope you enjoyed this webinar.
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Drink Up! How Much Water Is Enough In The Management Of Autosomal Dominant Polycystic Kidney Disease (ADPKD)?
Background

We’re excited to present Chef JJ Johnson to the NephU & NephChef communities! In this series Chef JJ will introduce himself and share his personal connection to kidney disease. He will advise viewers how to shop for kidney healthy ingredients and recommend essentials to have in the pantry. Best of all, in several episodes, viewers will be able to cook alongside Chef JJ’s demonstrations as he brings his culinary flare to three delicious kidney healthy recipes.

Registered Dietician and nutritionist Misty Nason will bring her expertise in renal nutrition to discuss important features of the kidney healthy diet. She will provide practical tips to successfully implement and maintain a kidney healthy diet.

Did You Know?

March is National Kidney Month!
Adopting a kidney healthy diet can help delay kidney disease progression and improve future outcomes.

Why Attend This Webinar?

Cooking for your kidneys doesn’t have to be challenging or boring! Chef JJ demonstrates how healthy food can be easy, exciting, and delicious. Not only can the whole family get involved, but they can have fun and enjoy the same meals as well.

What You Will Learn

In this Episode:

Get to know Chef JJ and his personal connection to kidney disease
Chef JJ will advise viewers how to stock their pantry with delicious kidney healthy ingredients
Misty Nason will provide context and nutritional profiles of Chef JJ’s essential ingredients

Featuring

Moderator

*JJ Johnson and Misty Nason are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Andrea Mohindra is an employee of OPDC.

Registration

Related Resources

Hot Topics in Nephrology – Ketogenic Diets for Polycystic Kidney Disease (PKD): Research Insights & Clinical Translation

Audio/Podcast April 10, 2025

In this episode, Dr. Thomas Weimbs discusses ketogenic diets for polycystic kidney disease (PKD), explaining the science behind ketosis and its potential impact.

Tofu Vegetable Stir-Fry

Recipe March 17, 2025

Recipe provided by Chef Anthony Valentine.

Cooking Demo: Dietary Considerations for Patients with IgA Nephropathy

On-Demand Webinar March 13, 2025

Registered Dietitian Lauren Levy and Kidney-Friendly Chef Anthony Valentine come together to bring their expertise in nutrition and IgAN, including discussing the basics of nutritional concepts – such as sodium…

American Kidney Fund’s Undiagnosed Causes Of Kidney Disease Initiative
2023-03-28 12:00 - 13:00
Thank you for attending, we hope you enjoyed this webinar.
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Drink Up! How Much Water Is Enough In The Management Of Autosomal Dominant Polycystic Kidney Disease (ADPKD)?
Background

Patients that do not have a definitive cause of their kidney disease may face many barriers or receive suboptimal care during their medical journey. The American Kidney Fund’s (AKF) Undiagnosed Causes of Kidney Disease Initiative seeks to improve the understanding of how undiagnosed or misdiagnosed causes of kidney disease directly impact patient care and outcomes, as well as gain insights of the patient journey to a rare kidney disease diagnosis.

Did You Know?

From a survey conducted by the AKF, the most commonly cited known cause of kidney disease was a history of high blood pressure, followed by history of diabetes. Only 6% had a diagnosed rare disease, while 27% had no known cause. Other cited causes included medications and cancer.

Why Attend This Webinar?

This webinar with the AKF will help promote meaningful, systemic change to ensure that patients with kidney disease get the diagnosis they need and the care they deserve. Overcoming barriers to identifying the root cause of kidney disease for currently unknown reasons, will not be accomplished quickly. However, thoughtful, dedicated collaboration among the kidney care community can result in steady progress toward expanding access to genetic testing, reducing systemic inequalities, engaging providers, and empowering patients.

What You Will Learn

Insight into the American Kidney Fund’s the Undiagnosed Causes of Kidney Disease (UCKD) initiative.
Preliminary data from survey conducted with HCPs to better understand when and how patients are being diagnosed (eg Primary Care, Referred to Nephrology, Etc).
Tools and action steps for healthcare providers to learn more, such as the Unknown Causes of Kidney Disease Project roadmap to promote meaningful, systemic change to ensure that patients with kidney disease get the diagnosis they need and the care they deserve.

References

Unknown Causes of Kidney Disease Project | American Kidney Fund

Featuring

*Michael Spigler is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Max Hyams is an employee of OPDC.

If you would like to register for the 9:00 pm to 10:00 pm EDT broadcast, please click below:

Register For The 9:00 pm Broadcast

Registration

Related Resources

Kidney Disease in Asian American & Pacific Islanders

On-Demand Webinar September 6, 2024

This webinar panel discussion featuring Dr. Naoka Murakami and Kelly Chen, NP-BC will discuss the prevalence of various common and rare kidney diseases and comorbidities among the Asian American and…

NephU Infographic – Kidney Disease Across The Lifespan

Infographic June 4, 2024

Kidney disease affects people of all ages across the lifespan, impacting both patients and families. This infographic will dive into the statistics of kidney disease across the lifespan spectrum.

Hot Topics In Nephrology: Preview Of The National Kidney Foundation Spring Clinical Meeting & The American Transplant Congress

Audio/Podcast May 23, 2024

In this Hot Topics podcast, Mark Neumann discusses the National Kidney Foundation (NKF) spring clinical meeting, and the American Transplant Congress.

American Kidney Fund’s Undiagnosed Causes Of Kidney Disease Initiative
2023-03-28 21:00 - 22:00
Thank you for attending, we hope you enjoyed this webinar.
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Drink Up! How Much Water Is Enough In The Management Of Autosomal Dominant Polycystic Kidney Disease (ADPKD)?
Background

Patients that do not have a definitive cause of their kidney disease may face many barriers or receive suboptimal care during their medical journey. The American Kidney Fund’s (AKF) Undiagnosed Causes of Kidney Disease Initiative seeks to improve the understanding of how undiagnosed or misdiagnosed causes of kidney disease directly impact patient care and outcomes, as well as gain insights of the patient journey to a rare kidney disease diagnosis.

Did You Know?

From a survey conducted by the AKF, the most commonly cited known cause of kidney disease was a history of high blood pressure, followed by history of diabetes. Only 6% had a diagnosed rare disease, while 27% had no known cause. Other cited causes included medications and cancer.

Why Attend This Webinar?

This webinar with the AKF will help promote meaningful, systemic change to ensure that patients with kidney disease get the diagnosis they need and the care they deserve. Overcoming barriers to identifying the root cause of kidney disease for currently unknown reasons, will not be accomplished quickly. However, thoughtful, dedicated collaboration among the kidney care community can result in steady progress toward expanding access to genetic testing, reducing systemic inequalities, engaging providers, and empowering patients.

What You Will Learn

Insight into the American Kidney Fund’s the Undiagnosed Causes of Kidney Disease (UCKD) initiative.
Preliminary data from survey conducted with HCPs to better understand when and how patients are being diagnosed (eg Primary Care, Referred to Nephrology, Etc).
Tools and action steps for healthcare providers to learn more, such as the Unknown Causes of Kidney Disease Project roadmap to promote meaningful, systemic change to ensure that patients with kidney disease get the diagnosis they need and the care they deserve.

References

Unknown Causes of Kidney Disease Project | American Kidney Fund

Featuring

*Michael Spigler is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Max Hyams is an employee of OPDC.

Registration

Related Resources

Kidney Disease in Asian American & Pacific Islanders

On-Demand Webinar September 6, 2024

This webinar panel discussion featuring Dr. Naoka Murakami and Kelly Chen, NP-BC will discuss the prevalence of various common and rare kidney diseases and comorbidities among the Asian American and…

NephU Infographic – Kidney Disease Across The Lifespan

Infographic June 4, 2024

Kidney disease affects people of all ages across the lifespan, impacting both patients and families. This infographic will dive into the statistics of kidney disease across the lifespan spectrum.

Hot Topics In Nephrology: Preview Of The National Kidney Foundation Spring Clinical Meeting & The American Transplant Congress

Audio/Podcast May 23, 2024

In this Hot Topics podcast, Mark Neumann discusses the National Kidney Foundation (NKF) spring clinical meeting, and the American Transplant Congress.

Mental Health Implications In Patients With End-Stage Kidney Disease
2023-04-19 13:00 - 14:00
Thank you for attending, we hope you enjoyed this webinar.
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Drink Up! How Much Water Is Enough In The Management Of Autosomal Dominant Polycystic Kidney Disease (ADPKD)?
(followed by a live Q&A with our speakers)

Background:

Depression and anxiety are the most common mood disorders amongst ESKD patients, which can negatively affect patient outcomes.1 The impact in end-stage kidney disease is often underrecognized and bringing awareness to this issue is critical to improving the management and overall well-being of these patients.

Why watch this webinar?

This webinar will illuminate the burden of depression and anxiety in ESKD patients and the associated risk factors. Best practices and strategies for recognizing and discussing these concerns with patients will be shared.

What you will learn:

Understand the mental health burden in ESKD and discuss current data on depression and anxiety in ESKD patients
Elucidate the factors associated with depression and anxiety in ESKD patients
Evaluate is the impact of depression and anxiety in ESKD patients
Discuss the role of nephrologists and the healthcare team in managing depression and anxiety in ESKD patients

Reference:

Al-Shammari N, Al-Modahka A, Al-Ansari E, et al. Prevalence of depression, anxiety, and their associations among end-stage renal disease patients on maintenance hemodialysis: a multi-center population-based study. Psychol Health Med. 2021 Oct;26(9):1134-1142. doi: 10.1080/13548506.2020.1852476. Epub 2020 Nov 29. PMID: 33251848.

Featuring

*Dr Fahad Aziz is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Jaimini Patel is an employee of OPDC.

Registration

Related Resources

Exploring The Kidney-Brain Connection: Anxiety & Depression In Chronic Kidney Disease

Downloadable Resource January 24, 2025

Define anxiety and depression, and discuss prevalence among chronic kidney disease (CKD) patients.

Mental Health In Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Infographic September 17, 2024

Learn how ADPKD can affect quality of life and psychosocial well-being.

On-Demand Webinar – Mental Health In Kidney Transplant Recipients

On-Demand Webinar February 14, 2024

Watch this on-demand webinar to learn more about mental health in kidney transplant recipients and how it impacts patients, caregivers, graft survival, and mortality.

Kidney Healthy Cooking Series Featuring Celebrity Chef JJ: Episode 2
2023-04-25 12:00 - 13:00
Thank you for attending, we hope you enjoyed this webinar.
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Drink Up! How Much Water Is Enough In The Management Of Autosomal Dominant Polycystic Kidney Disease (ADPKD)?
Background

We’re excited to present Chef JJ Johnson to the NephU & NephChef communities! In this series Chef JJ will introduce himself and share his personal connection to kidney disease. He will advise viewers how to shop for kidney healthy ingredients and recommend essentials to have in the pantry. Best of all, in several episodes, viewers will be able to cook alongside Chef JJ’s demonstrations as he brings his culinary flare to three delicious kidney healthy recipes.

Registered Dietician and nutritionist Misty Nason will bring her expertise in renal nutrition to discuss important features of the kidney healthy diet. She will provide practical tips to successfully implement and maintain a kidney healthy diet.

Did You Know?

Adopting a kidney healthy diet can help delay kidney disease progression and improve future outcomes.

Why Attend This Webinar?

Cooking for your kidneys doesn’t have to be challenging or boring! Chef JJ demonstrates how healthy food can be easy, exciting, and delicious. Not only can the whole family get involved, but they can have fun and enjoy the same meals as well.

What You Will Learn

In this Episode:

Cook alongside Chef JJ as he prepares a delicious kidney friendly meal

Sourdough Toast with Black-eyed Peas and Goat Cheese

Misty Nason will provide context and nutritional profiles of Chef JJ’s essential ingredients

Featuring

Moderator

*JJ Johnson and Misty Nason are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Andrea Mohindra is an employee of OPDC.

Registration

Related Resources

Hot Topics in Nephrology – Ketogenic Diets for Polycystic Kidney Disease (PKD): Research Insights & Clinical Translation

Audio/Podcast April 10, 2025

In this episode, Dr. Thomas Weimbs discusses ketogenic diets for polycystic kidney disease (PKD), explaining the science behind ketosis and its potential impact.

Tofu Vegetable Stir-Fry

Recipe March 17, 2025

Recipe provided by Chef Anthony Valentine.

Cooking Demo: Dietary Considerations for Patients with IgA Nephropathy

On-Demand Webinar March 13, 2025

Registered Dietitian Lauren Levy and Kidney-Friendly Chef Anthony Valentine come together to bring their expertise in nutrition and IgAN, including discussing the basics of nutritional concepts – such as sodium…

Current Understanding Of IgA Nephropathy (IgAN)
2023-05-11 12:00 - 13:00
Thank you for attending, we hope you enjoyed this webinar.
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Drink Up! How Much Water Is Enough In The Management Of Autosomal Dominant Polycystic Kidney Disease (ADPKD)?
Background

IgA Nephropathy (IgAN) is an autoimmune disease characterized by the production of abnormal IgA, an immune response, and deposits of IgA-containing immune complexes in glomeruli causing damage1. Which left unaddressed, the relentless damage to glomeruli can lead to kidney failure and the need for renal replacement therapy, such as transplant or dialysis2. The current model of pathogenicity involves four hits that drive the disease development and progression2.

Did You Know?

Immunoglobulin A Nephropathy (IgAN), also known as Berger’s disease, is the most common glomerulonephritis worldwide1
Of those affected with IgAN, 20-40% progress to kidney failure1

Why Attend This Webinar?

Join us for our webinar where expert, Dr. Ankur Shah, will provide an overview of IgA Nephropathy

What You Will Learn

Prevalence, epidemiology, and pathogenesis of IgAN
Signs and symptoms of IgAN
Diagnosis and general management strategies of IgAN per KDIGO guidelines

References

NephU_Overview of IgAN_2022 Infographic – US.CORP.X.22.00054
NephU_The “Four Hit” IgA Nephropathy (IgAN) Pathogenesis Theory_2022 Infographic – US.CORP.X.22.00055

Featuring

Moderating

*Dr Shah is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Drs Josh Gariboldi and Hannah Lambert are employees of OPDC.

Registration

Related Resources

Biomarkers in IgA Nephropathy

On-Demand Webinar December 3, 2025

This webinar will focus on the current biomarker landscape as well as novel biomarkers that are currently being studied. The webinar will also focus on why biomarkers are needed and…

Basic Anatomy of Glomerulus & IgAN Pathology

Infographic November 7, 2025

This infographic will give an opportunity to learn more about where IgA deposits in the kidney and how the depositions impact the patient’s outcome.

Navigating the Differential Diagnosis of Proteinuria with an Emphasis on IgA Nephropathy

On-Demand Webinar October 3, 2025

To enhance your understanding of the presentation, differential diagnosis, and workup of proteinuria. There is also the opportunity to explore the pathophysiology and risk of progression of IgA nephropathy and…

Discover The PKD Foundation’s ADPKD Centers Of Excellence Program
2023-05-23 12:00 - 13:00
Thank you for attending, we hope you enjoyed this webinar.
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Drink Up! How Much Water Is Enough In The Management Of Autosomal Dominant Polycystic Kidney Disease (ADPKD)?
Background

The PKD Foundation’s Centers of Excellence (COE) program is built upon the belief that the best way to provide ADPKD-centered care is through patient-focused, comprehensive care with the coordination and support of an integrated care team.

The program’s mission stands on three pillars:

understanding Polycystic Kidney Disease (PKD) through research
ensuring better care for all individuals with Autosomal Dominant Polycystic Kidney Disease (ADPKD)
educating and empowering the community.

Why Attend This Webinar?

Take a deep dive into the PKD Foundation COE initiative to coordinate and standardize specialty care for patients with PKD, which includes the professional network created between Centers of Excellence and designated Partner Clinics across the United States.
Be part of the PKD professional community that is empowering patients, advancing research, and optimizing care for those affected by PKD in hopes of improving outcomes.
Receive information on how to apply to the program and hear from the PKD Foundation about the critical deadlines for the 2023 application cycle.

Featuring

Moderator

*Elise Hoover is an unpaid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Tazin Aijaz is an employee of OPDC.

If you would like to register for the 9:00 pm to 10:00 pm EDT broadcast, please click below:

Register For The 9:00 pm Broadcast

Registration

Related Resources

Biomarkers in IgA Nephropathy

On-Demand Webinar December 3, 2025

This webinar will focus on the current biomarker landscape as well as novel biomarkers that are currently being studied. The webinar will also focus on why biomarkers are needed and…

Basic Anatomy of Glomerulus & IgAN Pathology

Infographic November 7, 2025

This infographic will give an opportunity to learn more about where IgA deposits in the kidney and how the depositions impact the patient’s outcome.

Navigating the Differential Diagnosis of Proteinuria with an Emphasis on IgA Nephropathy

On-Demand Webinar October 3, 2025

To enhance your understanding of the presentation, differential diagnosis, and workup of proteinuria. There is also the opportunity to explore the pathophysiology and risk of progression of IgA nephropathy and…

Discover The PKD Foundation’s ADPKD Centers Of Excellence Program
2023-05-23 21:00 - 22:00
Thank you for attending, we hope you enjoyed this webinar.
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Drink Up! How Much Water Is Enough In The Management Of Autosomal Dominant Polycystic Kidney Disease (ADPKD)?
Background

The PKD Foundation’s Centers of Excellence (COE) program is built upon the belief that the best way to provide ADPKD-centered care is through patient-focused, comprehensive care with the coordination and support of an integrated care team.

The program’s mission stands on three pillars:

understanding Polycystic Kidney Disease (PKD) through research
ensuring better care for all individuals with Autosomal Dominant Polycystic Kidney Disease (ADPKD)
educating and empowering the community.

Why Attend This Webinar?

Take a deep dive into the PKD Foundation COE initiative to coordinate and standardize specialty care for patients with PKD, which includes the professional network created between Centers of Excellence and designated Partner Clinics across the United States.
Be part of the PKD professional community that is empowering patients, advancing research, and optimizing care for those affected by PKD in hopes of improving outcomes.
Receive information on how to apply to the program and hear from the PKD Foundation about the critical deadlines for the 2023 application cycle.

Featuring

Moderator

*Elise Hoover is an unpaid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Tazin Aijaz is an employee of OPDC.

Registration

Related Resources

Biomarkers in IgA Nephropathy

On-Demand Webinar December 3, 2025

This webinar will focus on the current biomarker landscape as well as novel biomarkers that are currently being studied. The webinar will also focus on why biomarkers are needed and…

Basic Anatomy of Glomerulus & IgAN Pathology

Infographic November 7, 2025

This infographic will give an opportunity to learn more about where IgA deposits in the kidney and how the depositions impact the patient’s outcome.

Navigating the Differential Diagnosis of Proteinuria with an Emphasis on IgA Nephropathy

On-Demand Webinar October 3, 2025

To enhance your understanding of the presentation, differential diagnosis, and workup of proteinuria. There is also the opportunity to explore the pathophysiology and risk of progression of IgA nephropathy and…

Kidney Healthy Cooking Series Featuring Celebrity Chef JJ: Episode 3
2023-06-06 12:00 - 13:00
Thank you for attending, we hope you enjoyed this webinar.
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Drink Up! How Much Water Is Enough In The Management Of Autosomal Dominant Polycystic Kidney Disease (ADPKD)?
Quinoa Fonio Crusted Salmon With Sautéed Collard Greens
Background

We’re excited to welcome back Chef JJ Johnson to the NephU & NephChef communities! In case you missed the first two episodes, in this series Chef JJ introduces himself and shares his personal connection to kidney disease. He advises viewers how to shop for kidney healthy ingredients and recommends essentials to have in the pantry as well. Best of all, in this episode among others, viewers can cook alongside Chef JJ’s demonstration as he brings his culinary flare to delicious kidney healthy recipes.

Registered Dietician and nutritionist Misty Nason will bring her expertise in renal nutrition to discuss important features of the kidney healthy diet. She will provide practical tips to successfully implement and maintain a kidney healthy diet.

Did You Know?

In June, NephU highlights Diversity, Equity, and Inclusion (DEI) in healthcare.
Adopting a kidney healthy diet can help delay kidney disease progression and improve future outcomes.

Why Attend This Webinar?

Cooking for your kidneys doesn’t have to be challenging or boring! Chef JJ demonstrates how healthy food can be easy, exciting, and delicious. Not only can the whole family get involved, but they can have fun and enjoy the same meals as well.

What You Will Learn

In this Episode:

Chef JJ highlights inclusivity by sharing his experiences preparing food while also being mindful of dietary restrictions and allergies so that everyone can feel comfortable and welcome at the table.
Chef JJ shares his culinary journey that has taken him to all corners of the world. He applies these diverse experiences to his recipes to tell the stories of many different cultures through his food.
Cook alongside Chef JJ as he prepares a delicious kidney friendly meal.

Quinoa Fonio Crusted Salmon with Sautéed Collard Greens.

Misty Nason will provide context and nutritional profiles of Chef JJ’s essential ingredients.
Misty Nason will share simple and practical methods for estimating portion sizes.

Featuring

Moderator

*JJ Johnson and Misty Nason are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Sushma Shiravanthe is an employee of OPDC.

Registration

Related Resources

Hot Topics in Nephrology – Ketogenic Diets for Polycystic Kidney Disease (PKD): Research Insights & Clinical Translation

Audio/Podcast April 10, 2025

In this episode, Dr. Thomas Weimbs discusses ketogenic diets for polycystic kidney disease (PKD), explaining the science behind ketosis and its potential impact.

Tofu Vegetable Stir-Fry

Recipe March 17, 2025

Recipe provided by Chef Anthony Valentine.

Cooking Demo: Dietary Considerations for Patients with IgA Nephropathy

On-Demand Webinar March 13, 2025

Registered Dietitian Lauren Levy and Kidney-Friendly Chef Anthony Valentine come together to bring their expertise in nutrition and IgAN, including discussing the basics of nutritional concepts – such as sodium…

Mental Health In Autosomal Dominant Polycystic Kidney Disease (ADPKD)
2023-06-15 12:00 - 13:00
Thank you for attending, we hope you enjoyed this webinar.
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Drink Up! How Much Water Is Enough In The Management Of Autosomal Dominant Polycystic Kidney Disease (ADPKD)?
Background

The psychological impact of ADPKD can negatively impact the patient outcomes. Currently there is a paucity of research in this area and as a result, mental health is underrecognized and underdiagnosed in this patient population. Early detection and treatment of mental health can improve quality of life and is as important as medical management. Bringing awareness to this issue is critical to improving the management and overall well-being of these patients.

Did You Know?

Even early on in ADPKD, ADPKD patients report a lower satisfaction with life compared to healthy persons.1

Why Attend This Webinar?

The goal of this webinar is to increase awareness surrounding the emotional and physical burden that ADPKD patients face. The webinar will also discuss the impact on patient’s caregivers as well as the urgent call to action for collaborative engagement between nephrology and mental health experts to address mental health in ADPKD patients.

What You Will Learn

Discuss the psychological impact of ADPKD (i.e., the biological mechanisms behind anxiety and depression in ADPKD) as well as the emotional burden these patients face
Discuss the quality of life in ADPKD patients and the impact on family and caregivers
Evaluate the morbidity and mortality outcomes in ADPKD patients
Assess what HCPs can do better in terms of empowering their ADPKD patients and properly addressing their mental health needs

References:

Yarlioglu, A.M., et al. Int Urol Nephrol. 2022 https://doi.org/10.1007/s11255-022-03375-2

Featuring

Moderating

*Dr Rebecca Ahdoot and Hannah Graves are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Drs Marla Dallal and Jaimini Patel are employees of OPDC.

Registration

Related Resources

Exploring The Kidney-Brain Connection: Anxiety & Depression In Chronic Kidney Disease

Downloadable Resource January 24, 2025

Define anxiety and depression, and discuss prevalence among chronic kidney disease (CKD) patients.

Mental Health In Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Infographic September 17, 2024

Learn how ADPKD can affect quality of life and psychosocial well-being.

On-Demand Webinar – Mental Health In Kidney Transplant Recipients

On-Demand Webinar February 14, 2024

Watch this on-demand webinar to learn more about mental health in kidney transplant recipients and how it impacts patients, caregivers, graft survival, and mortality.

Metabolic Acidosis In Chronic Kidney Disease (CKD)
2023-07-13 12:00 - 12:30
Thank you for attending, we hope you enjoyed this webinar.
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Drink Up! How Much Water Is Enough In The Management Of Autosomal Dominant Polycystic Kidney Disease (ADPKD)?
Background

Metabolic acidosis in chronic kidney disease (CKD), defined as total CO2 <22 mEq/L, is one of the earliest complications of CKD and has been identified as risk factor for CKD progression, renal replacement therapy, mortality.1,2,3 While metabolic acidosis can be present all different stages of CKD, it is most common in patients with eGFR <40 mL/min/1.73 m2.1 Some studies suggest that correcting metabolic acidosis with alkali therapy may slow down CKD progression.1,4

Did You Know?

In non-dialysis CKD 3-5 patients with metabolic acidosis, a 1mEq/L increase in serum bicarbonate was associated with a 13% reduction in a 2-year composite DD40 (death, dialysis, or 40% reduction in eGFR), and a 7% reduction in per-patient per-year cost?5

Why Attend This Webinar?

Expert nephrologist, Dr. Samuel A Kantor, will discuss metabolic acidosis in CKD.

What You Will Learn

The relationship between metabolic acidosis and hyperkalemia in chronic kidney disease (CKD)
The role of metabolic acidosis in CKD progression and other complications
The role of alkali replacement in metabolic acidosis treatment

References

Raphael Kl. Am J Kidney Dis. 2019;74(2):263-275.
Wesson DE, Buysse JM, Bushinsky DA. J Am Soc Nephrol. 2020 ;31 :469-482.
Tangri N, et al. BMC Nephrology. 2021;22(185):1-11.
Navaneethan SD, Shao J, Buysse J, et al. Clin J Am Soc Nephrol. 2019 ;14(7) :1011-1020. DOI : 10.2215/CJN.13091118.
Reaven NL, Funk SE, Mathur V, et al. Kidney Med. 2023;5(5):1-8.

Featuring

Moderating

*Dr Samuel Kantor is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Rim Hadgu is an employee of OPDC.

Registration

Related Resources

Kidney Disease in Asian American & Pacific Islanders

On-Demand Webinar September 6, 2024

This webinar panel discussion featuring Dr. Naoka Murakami and Kelly Chen, NP-BC will discuss the prevalence of various common and rare kidney diseases and comorbidities among the Asian American and…

NephU Infographic – Kidney Disease Across The Lifespan

Infographic June 4, 2024

Kidney disease affects people of all ages across the lifespan, impacting both patients and families. This infographic will dive into the statistics of kidney disease across the lifespan spectrum.

Hot Topics In Nephrology: Preview Of The National Kidney Foundation Spring Clinical Meeting & The American Transplant Congress

Audio/Podcast May 23, 2024

In this Hot Topics podcast, Mark Neumann discusses the National Kidney Foundation (NKF) spring clinical meeting, and the American Transplant Congress.

Factors Influencing Drug Dialyzability
2023-08-24 12:00 - 13:00
Thank you for attending, we hope you enjoyed this webinar.
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Drink Up! How Much Water Is Enough In The Management Of Autosomal Dominant Polycystic Kidney Disease (ADPKD)?
Background

Deciding when to administer a medication around chronic dialysis can be a complex process in the clinical setting. Dr George Bailie and Dr Nancy Mason will present information about the medication-related and dialysis-related factors that influence medication removal by hemodialysis and peritoneal dialysis. They will review medication information resources on this topic, and also present an approach to administration of medications when dialyzability data are limited.

Why View This Webinar?

In this webinar, the speakers will review medication information resources and present an approach to administration of medications when dialyzability data are limited in the hemodialysis and peritoneal dialysis populations.

What You Will Learn

Drug-related and dialysis-related factors that influence drug dialyzability
How drug removal by high-flux hemodialysis can be different from that by low-flux hemodialysis
The effects of ratios of systemic volume of distribution to dialysate volume in various peritoneal dialysis regimens on drug clearance
How to use drug information resources to find dialysis dosing recommendations or pharmacokinetic drug data
How to use a step-wise approach to determine the appropriate drug dosing time around dialysis

Featuring

Moderator

*Drs George Bailie and Nancy Mason are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Jaimini Patel is an employee of OPDC.

Registration

Related Resources

Kidney Disease in Asian American & Pacific Islanders

On-Demand Webinar September 6, 2024

This webinar panel discussion featuring Dr. Naoka Murakami and Kelly Chen, NP-BC will discuss the prevalence of various common and rare kidney diseases and comorbidities among the Asian American and…

NephU Infographic – Kidney Disease Across The Lifespan

Infographic June 4, 2024

Kidney disease affects people of all ages across the lifespan, impacting both patients and families. This infographic will dive into the statistics of kidney disease across the lifespan spectrum.

Hot Topics In Nephrology: Preview Of The National Kidney Foundation Spring Clinical Meeting & The American Transplant Congress

Audio/Podcast May 23, 2024

In this Hot Topics podcast, Mark Neumann discusses the National Kidney Foundation (NKF) spring clinical meeting, and the American Transplant Congress.

Role Of Obesity & Diet In Polycystic Kidney Disease (PKD) Progression
2023-09-12 12:00 - 13:00
Thank you for attending, we hope you enjoyed this webinar.
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Drink Up! How Much Water Is Enough In The Management Of Autosomal Dominant Polycystic Kidney Disease (ADPKD)?
Polycystic Kidney Disease (PKD) is the most commonly inherited disease that can lead to kidney failure. The role of various diets in PKD disease progression is a hot topic among researchers and clinicians. In addition, a new study established that being overweight and obese are risk factors in PKD progression.1

Please join us and our leading expert, Kristen Nowak, PhD, MPH, as she showcases her laboratory findings about the complex relationship between diet, obesity and the role that they play in disease progression.

Nowak K et al, JASN, 2018 Feb; 29(2): 571–578

Featuring

*Dr Kristen Nowak is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Drs Hannah Lambert and Sachin Hajarnis are employees of OPDC.

If you would like to register for the 9:00 pm to 10:00 pm EDT broadcast, please click below:

Register For The 9:00 pm Broadcast

Registration

Related Resources

Hot Topics in Nephrology: Ketogenic Diets for Polycystic Kidney Disease (PKD): Insights from a Renal Dietitian

Audio/Podcast March 20, 2025

In this episode, renal dietitian Kelly Welsh discusses ketogenic diets for polycystic kidney disease (PKD). She explains the fundamentals of a ketogenic diet, how ketosis works, and shares strategies for…

Tofu Vegetable Stir-Fry

Recipe March 17, 2025

Recipe provided by Chef Anthony Valentine.

Cooking Demo: Dietary Considerations for Patients with IgA Nephropathy

On-Demand Webinar March 13, 2025

Registered Dietitian Lauren Levy and Kidney-Friendly Chef Anthony Valentine come together to bring their expertise in nutrition and IgAN, including discussing the basics of nutritional concepts – such as sodium…

Role Of Obesity & Diet In Polycystic Kidney Disease (PKD) Progression
2023-09-12 21:00 - 22:00
Thank you for attending, we hope you enjoyed this webinar.
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Drink Up! How Much Water Is Enough In The Management Of Autosomal Dominant Polycystic Kidney Disease (ADPKD)?
Polycystic Kidney Disease (PKD) is the most commonly inherited disease that can lead to kidney failure. The role of various diets in PKD disease progression is a hot topic among researchers and clinicians. In addition, a new study established that being overweight and obese are risk factors in PKD progression.1

Please join us and our leading expert, Kristen Nowak, PhD, MPH, as she showcases her laboratory findings about the complex relationship between diet, obesity and the role that they play in disease progression.

Nowak K et al, JASN, 2018 Feb; 29(2): 571–578

Featuring

*Dr Kristen Nowak is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Drs Hannah Lambert and Sachin Hajarnis are employees of OPDC.

Registration

Related Resources

Hot Topics in Nephrology: Ketogenic Diets for Polycystic Kidney Disease (PKD): Insights from a Renal Dietitian

Audio/Podcast March 20, 2025

In this episode, renal dietitian Kelly Welsh discusses ketogenic diets for polycystic kidney disease (PKD). She explains the fundamentals of a ketogenic diet, how ketosis works, and shares strategies for…

Tofu Vegetable Stir-Fry

Recipe March 17, 2025

Recipe provided by Chef Anthony Valentine.

Cooking Demo: Dietary Considerations for Patients with IgA Nephropathy

On-Demand Webinar March 13, 2025

Registered Dietitian Lauren Levy and Kidney-Friendly Chef Anthony Valentine come together to bring their expertise in nutrition and IgAN, including discussing the basics of nutritional concepts – such as sodium…

Assessing Pain And Its Impact In Autosomal Dominant Polycystic Kidney Disease (ADPKD): The ADPKD Pain And Discomfort Scale (ADPKD - PDS)
2023-09-19 12:00 - 13:00
Thank you for attending, we hope you enjoyed this webinar.
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Drink Up! How Much Water Is Enough In The Management Of Autosomal Dominant Polycystic Kidney Disease (ADPKD)?
Background
Autosomal Dominant Polycystic Kidney Disease (ADPKD), an inherited progressive kidney disease, is the fourth leading cause of kidney failure in the US. Approximately 60% of primary complaints for ADPKD patients involved pain.1 Pain can be described as sharp, dull, acute and/or chronic, depending on the source.1 Patients have shared that pain and their large cystic kidneys often limited their daily activities, causing mental and physical fatigue.2 The Autosomal Dominant Polycystic Kidney Disease Pain & Discomfort Scale (ADPKD-PDS) has been developed and validated as a patient-reported outcomes (PRO) tool.2 While pain continues to be a challenging issue for patients with ADPKD and their health care teams, utilizing a validated tool such as the ADPKD-PDS can facilitate patient-health care professionals’ discussions about ADPKD-associated pain and its impact on patients and their families.2
Did you Know?

Individuals with ADPKD have identified inadequate pain management and trivialization of their pain by physicians as key concerns, pointing to the need for tools to address ADPKD-related pain.3
The ADPKD-PDS tool was developed through a multi-step collaboration involving 26 clinical experts and 298 patient participants (46 patient focus groups across 18 countries).

Why Attend This Webinar?

Join us for this webinar to learn more about the impact of pain in patients with ADPKD and how the new ADPKD-PDS tool can enable standardized assessment of the severity and impact of pain/discomfort in clinical trials and practice settings

What You Will Learn

Why evaluate pain in ADPKD?
Development process of the ADPKD-PDS
Types of pain identified and evaluated in this PRO tool

References

Bajwa ZH et al. Kidney Int. 2004;66:1561-9.
Oberdhan DO et al. Clin J Am Soc Nephrol. 2023;18:213-22.
Cho Y et al. Am J Kidney Dis. 2021;77:255-63.

Featuring

Moderator

*Dr Pranav Garimella is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Josh Gariboldi is an employee of OPDC.

Registration

Related Resources

Kidney Disease in Asian American & Pacific Islanders

On-Demand Webinar September 6, 2024

This webinar panel discussion featuring Dr. Naoka Murakami and Kelly Chen, NP-BC will discuss the prevalence of various common and rare kidney diseases and comorbidities among the Asian American and…

NephU Infographic – Kidney Disease Across The Lifespan

Infographic June 4, 2024

Kidney disease affects people of all ages across the lifespan, impacting both patients and families. This infographic will dive into the statistics of kidney disease across the lifespan spectrum.

Hot Topics In Nephrology: Preview Of The National Kidney Foundation Spring Clinical Meeting & The American Transplant Congress

Audio/Podcast May 23, 2024

In this Hot Topics podcast, Mark Neumann discusses the National Kidney Foundation (NKF) spring clinical meeting, and the American Transplant Congress.

Screening & Differential Diagnosis For Autosomal Dominant Polycystic Kidney Disease (ADPKD)
2023-09-27 12:00 - 13:00
Thank you for attending, we hope you enjoyed this webinar.
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Drink Up! How Much Water Is Enough In The Management Of Autosomal Dominant Polycystic Kidney Disease (ADPKD)?
Background:
In most cases of ADPKD, the diagnosis is straightforward, with patients presenting with enlarged cystic kidneys and a positive family history.1 However, in some cases, the diagnosis can be a bit more complicated. A small number of cases (~5%) occur due to spontaneous (de novo) mutations,2 but a lack of family history is reported in as many as 25% of newly diagnosed cases, suggesting that many familial cases go undetected.2 Additionally, there are several rare conditions that can present with cystic kidneys and may be considered during the differential diagnosis of ADPKD.1

Why watch this webinar?
Expert speakers will discuss a diagnostic work up for ADPKD and walk through a diagnostic algorithm including a differential diagnosis for cystic kidney disease. Best practices for different imaging modalities and genetic testing will be reviewed.

What you will learn:

When to utilize different imagining modalities for diagnosis and prognosis of polycystic kidney disease
When it may be appropriate to incorporate genetic testing
If not ADPKD, then what could it be?
Best practices for obtaining the most accurate results for patients

Featuring

Moderator

*Drs Ranine Ghamrawi and Edgar Lerma are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Kelly Reed is an employee of OPDC.

If you would like to register for the 6:00 pm to 7:00 pm EST broadcast, please click here.

Registration

Related Resources

Biomarkers in IgA Nephropathy

On-Demand Webinar December 3, 2025

This webinar will focus on the current biomarker landscape as well as novel biomarkers that are currently being studied. The webinar will also focus on why biomarkers are needed and…

Basic Anatomy of Glomerulus & IgAN Pathology

Infographic November 7, 2025

This infographic will give an opportunity to learn more about where IgA deposits in the kidney and how the depositions impact the patient’s outcome.

Navigating the Differential Diagnosis of Proteinuria with an Emphasis on IgA Nephropathy

On-Demand Webinar October 3, 2025

To enhance your understanding of the presentation, differential diagnosis, and workup of proteinuria. There is also the opportunity to explore the pathophysiology and risk of progression of IgA nephropathy and…

Screening & Differential Diagnosis For Autosomal Dominant Polycystic Kidney Disease (ADPKD)
2023-09-27 18:00 - 19:00
Thank you for attending, we hope you enjoyed this webinar.
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Drink Up! How Much Water Is Enough In The Management Of Autosomal Dominant Polycystic Kidney Disease (ADPKD)?
Background:

In most cases of ADPKD, the diagnosis is straightforward, with patients presenting with enlarged cystic kidneys and a positive family history.1 However, in some cases, the diagnosis can be a bit more complicated. A small number of cases (~5%) occur due to spontaneous (de novo) mutations,2 but a lack of family history is reported in as many as 25% of newly diagnosed cases, suggesting that many familial cases go undetected.2 Additionally, there are several rare conditions that can present with cystic kidneys and may be considered during the differential diagnosis of ADPKD.1

Why watch this webinar?

Expert speakers will discuss a diagnostic work up for ADPKD and walk through a diagnostic algorithm including a differential diagnosis for cystic kidney disease. Best practices for different imaging modalities and genetic testing will be reviewed.

What you will learn:

When to utilize different imagining modalities for diagnosis and prognosis of polycystic kidney disease
When it may be appropriate to incorporate genetic testing
If not ADPKD, then what could it be?
Best practices for obtaining the most accurate results for patients

Featuring

Moderator

*Drs Ranine Ghamrawi and Edgar Lerma are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Kelly Reed is an employee of OPDC.

Registration

Related Resources

Biomarkers in IgA Nephropathy

On-Demand Webinar December 3, 2025

This webinar will focus on the current biomarker landscape as well as novel biomarkers that are currently being studied. The webinar will also focus on why biomarkers are needed and…

Basic Anatomy of Glomerulus & IgAN Pathology

Infographic November 7, 2025

This infographic will give an opportunity to learn more about where IgA deposits in the kidney and how the depositions impact the patient’s outcome.

Navigating the Differential Diagnosis of Proteinuria with an Emphasis on IgA Nephropathy

On-Demand Webinar October 3, 2025

To enhance your understanding of the presentation, differential diagnosis, and workup of proteinuria. There is also the opportunity to explore the pathophysiology and risk of progression of IgA nephropathy and…

Kidney Healthy Cooking Series With Celebrity Chef JJ - Episode 4: Pumpkin Pancakes With Berry Compote
2023-10-12 12:00 - 13:00
Thank you for attending, we hope you enjoyed this webinar.
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Drink Up! How Much Water Is Enough In The Management Of Autosomal Dominant Polycystic Kidney Disease (ADPKD)?
Background
We’re excited to welcome back Chef JJ Johnson to the NephU & NephChef communities in Episode 4 of the Kidney Healthy Cooking Series! In case you missed the first three episodes, in this series Chef JJ introduces himself and shares his personal connection to kidney disease. He advises viewers how to shop for kidney-healthy ingredients and recommends essentials to have in the pantry as well. Best of all, in this episode among others, viewers can cook alongside Chef JJ’s demonstration as he brings his culinary flare to delicious kidney-healthy recipes.

Registered Dietitian Nutritionist Misty Nason will bring her expertise in renal nutrition to discuss important features of the kidney-healthy diet. She will provide practical tips to successfully implement and maintain a kidney-healthy diet.

Did You Know?

It’s fall y’all! Celebrate pumpkin spice and everything nice with this fall themed pumpkin pancakes recipe.
Adopting a kidney healthy diet can help delay kidney disease progression and improve future outcomes.

Why Attend This Webinar?

Cooking for your kidneys doesn’t have to be challenging or boring! Chef JJ demonstrates how healthy food can be easy, exciting, and delicious. Not only can the whole family get involved, but they can have fun and enjoy the same meals as well.

What You Will Learn

In this Episode:

Cook alongside Chef JJ as he prepares a delicious kidney friendly meal

Pumpkin Pancakes with Berry Compote

Misty Nason will provide context and nutritional profiles of Chef JJ’s essential ingredients

Milk Alternatives
Healthy Fats
Antioxidants
Carbohydrates

Featuring

Moderator

*JJ Johnson and Misty Nason are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Molly Jansen is an employee of OPDC.

Registration

Related Resources

Hot Topics in Nephrology – Ketogenic Diets for Polycystic Kidney Disease (PKD): Research Insights & Clinical Translation

Audio/Podcast April 10, 2025

In this episode, Dr. Thomas Weimbs discusses ketogenic diets for polycystic kidney disease (PKD), explaining the science behind ketosis and its potential impact.

Tofu Vegetable Stir-Fry

Recipe March 17, 2025

Recipe provided by Chef Anthony Valentine.

Cooking Demo: Dietary Considerations for Patients with IgA Nephropathy

On-Demand Webinar March 13, 2025

Registered Dietitian Lauren Levy and Kidney-Friendly Chef Anthony Valentine come together to bring their expertise in nutrition and IgAN, including discussing the basics of nutritional concepts – such as sodium…

Hypertension In Autosomal Dominant Polycystic Kidney Disease (ADPKD), Chronic Kidney Disease (CKD), & The General Population
2023-10-31 12:00 - 13:00
Thank you for attending, we hope you enjoyed this webinar.
Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Drink Up! How Much Water Is Enough In The Management Of Autosomal Dominant Polycystic Kidney Disease (ADPKD)?
Background
Hypertension (HTN) is the first complication of ADPKD in 30% of patients and it is more common among men than women. Approximately 20% of patients <20 years old have HTN. Earlier onset of HTN is more common with PKD1 mutation compared to PKD2 and also if a parent with ADPKD has HTN.1,2 Hypertensive patients with ADPKD and preserved kidney function have greater total kidney volume (TKV), higher proteinuria, and decreased renal blood flow than normotensive patients with ADPKD.2 The mechanism is incompletely understood and there are similarities and differences in the pathophysiology and management of HTN in patients with ADPKD, CKD, and the general population (GP).

Did You Know?

Hypertension precedes kidney function loss in >60% of patients with ADPKD.2

Why Attend This Webinar?

Dr. Workeneh, a double Board-certified nephrologist and internist, and professor will discuss the pathophysiology and management of HTN in patients with ADPKD, CKD, and the GP.

What You Will Learn
1. The pathophysiology of ADPKD and HTN
2. The pathophysiology of HTN in the GP versus patients with ADPKD and CKD
3. The management of HTN in the GP, in patients with ADPKD, and CKD
References
1. Rahbari-Oskoui F, Williams O, Chapman A. Nephrology Dialysis Transplantation.
2014;29(12):2194-2201.
2. Chapman AB, Stepniakowski K, Rahbari-Oskoui F. Adv Chronic Kidney Dis. 2010;17(2):153-163.

Featuring

Moderator

*Dr Biruh Workeneh is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Drs Rim Hadgu & Jessica Kanai are employees of OPDC.

Registration

Related Resources

Hot Topics in Nephrology – Ketogenic Diets for Polycystic Kidney Disease (PKD): Research Insights & Clinical Translation

Audio/Podcast April 10, 2025

In this episode, Dr. Thomas Weimbs discusses ketogenic diets for polycystic kidney disease (PKD), explaining the science behind ketosis and its potential impact.

Tofu Vegetable Stir-Fry

Recipe March 17, 2025

Recipe provided by Chef Anthony Valentine.

Cooking Demo: Dietary Considerations for Patients with IgA Nephropathy

On-Demand Webinar March 13, 2025

Registered Dietitian Lauren Levy and Kidney-Friendly Chef Anthony Valentine come together to bring their expertise in nutrition and IgAN, including discussing the basics of nutritional concepts – such as sodium…
